|
Match
|
Document |
Document Title |
|
|
5827886 |
Composition for relief of arthritis-induced symptoms
A composition and method of using it for ameliorating inflammatory reactions and painful and other symptoms of the diseases of arthritis, lumbago, low back pain, myalgias and neuralgias. The...
|
|
|
5824708 |
Virucidal substances
The process of reducing the count of a virus by contacting the virus with (1) the reaction product of a) N-substituted propylenediamines corresponding to formula I: R 1 --NH--CH 2 --CH 2 ...
|
|
|
5817621 |
External remedy possessing trophoprotective effect
A dermatological composition for external use comprising a lipid ointment base, vitamin A, a salicylic acid or a derivative thereof, D-camphor, a biogenic GABAergic substance, a biogenic...
|
|
|
5817695 |
Nutritional product with high fat, low carbohydrate and amino acid imbalance
A nutritional product is provided for cancer patients comprising, as per caloric requirement, a low concentration of carbohydrate, a high concentration of fat and an imbalance of amino acids...
|
|
|
5817329 |
Nutritional supplement for increased muscle size and strength for body builders
The present invention relates to the method and composition for use of diet supplements by athletes and bodybuilders. A first supplement comprising, the amino acid acetyl-L-Carnitine, in...
|
|
|
5798363 |
Use for tachykinin antagonists to treat emesis
The present invention relates to the use of tachykinin antagonists, including substance P antagonists and other neurokinin antagonists, in the treatment of emesis. Also described are novel...
|
|
|
5798371 |
Pharmaceutical composition endowed with an antialcoholic and nootropic effect
A pharmaceutical composition having an antialcoholic and nootropic effect which is administered sublingually. The active ingredients of the composition are the amino acid L-threonine or a...
|
|
|
5792796 |
Methods for treating anxiety and panic
The instant invention is novel uses of known cyclic amino acids. Such compounds as gabapentin are useful in the treatment of anxiety and in the treatment and/or prevention of panic attacks.
|
|
|
5789443 |
Method for treating flushing associated with menopause
A method for treating flushing as a symptom of menopause is disclosed. Specifically, the method comprises administering to a patient in need thereof an effective amount of leucine, or leucine in...
|
|
|
5788958 |
Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
The present invention is directed to the use of an inhibitor of NO activity, such as a nitric oxide scavenger or an NO synthase inhibitor, as an antitumor therapy to reduce tumor blood flow and...
|
|
|
5783593 |
Inhibitors of squalene synthetase and protein farnesyltransferase
The present invention provides a compound of the formula ##STR1## which inhibit squalene synthetase and cholesterol biosynthesis and are useful in the treatment of e.g., hyperlipidaemia,...
|
|
|
5776503 |
Amino acid solutions for treatment of peritoneal dialysis patients
The present invention provides a dialysis solution that contains amino acids for treating and/or preventing malnutrition in a peritoneal dialysis patient. The amino acid composition is optimized to...
|
|
|
5770622 |
Method of preserving materials using 4-methylene-2-amino-cyclopentane-1-carboxylic acids
The invention relates to cyclopentane- and -pentene-β-amino acids, processes for their preparation and their use as medicaments, and to prevent contamination of materials such as wood and leather.
|
|
|
5770619 |
Method of activating photosensitive agents
A method of administering photodynamic therapy begins with administering to an animal an effective amount of a photosensitizing agent which is less than about one half of the usual clinical dose...
|
|
|
5767091 |
Analgesic effect enhancing preparations
The present invention provides an analgesic effect enhancing preparation capable of enhancement of the effect of analgesics, the preparation comprising as an active ingredient the following amino...
|
|
|
5753254 |
Therapeutic agents containing thyroid hormones
There is disclosed a solid fast dispersing dosage form of a pharmaceutical composition suitable for oral administration comprising: a therapeutic agent which comprises one or more compound thyroid...
|
|
|
5750558 |
Oxime derivatives of indole and indene compounds as inhibitors of prostaglandin biosynthesis
Described herein are compounds having the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein L is selected from the group consisting of ##STR2## R 2 is selected from (a)...
|
|
|
5746998 |
Targeted co-polymers for radiographic imaging
A radiographic imaging agent including a plurality of block copolymers forming a micelle, the block copolymers including a hydrophilic polymer linked to a hydrophobic polymer, and the hydrophobic...
|
|
|
5741817 |
Use of low molecular weight amino acids in ophthalmic compositions
The use of glycine and other low molecular weight amino acids in ophthalmic compositions (e.g., preserved saline solutions) is described. These compounds have been found to enhance the efficacy of...
|
|
|
5739163 |
Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
This invention relates to novel compounds containing basic and acidic termini, pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using...
|
|
|
5739160 |
Cyclopentane- and -pentene-β-amino acids
New Cyclopentane- or cyclopentene-beta-aminoacid derivatives and their isomers, acid additional salts and metal salt complexes have strong antimicrobial and broad-spectrum antimycotic acitivity. As...
|
|
|
5739164 |
Pharmaceutical compounds for the treatment of CNS diseases
Disclosed herein is a method of treating a disease of the central nervous system with a compound of the formula ##STR1## in which m is 0, 1 or 2, n and q are each 0 or 1 to 5, and p is 0 or 1, X is...
|
|
|
5736563 |
Transcutaneous in vivo activation of photosensitive agents in blood
A method destroys or impairs target cells that have selectively accumulated a photosensitizing agent. The target cells are in the bloodstream of an intact animal, which bloodstream and animal...
|
|
|
5733539 |
Bait for fishes and shellfishes
The invention discloses a bait for fishes and shellfishes characterized in that the bait comprises a matrix material containing a microorganically fermented product of a plant residue obtained by...
|
|
|
5731290 |
Method of improving the immune response
The invention provides diet supplements for pre-operative treatment of patients due for surgery.
|
|
|
5731349 |
Medicinal preparation of antistress, stess-protective and nootropic effect
A pharmaceutical preparation of antistress, stress-protective and nootropic effect contains an effective substance represented by an amino-acid glycine or its pharmaceutically acceptable salt. A...
|
|
|
5731348 |
Alkylcarboxy amino acids-modulators of the kainate receptor
Compounds of a new class of alkyl carboxy amino acid analogs of glutamic acid act as specific regulators of the kainic acid EAA receptor cation channel. These compounds are useful for treating...
|
|
|
5728678 |
Method and composition for providing nutrition to a renal failure patient
The present invention provides a composition as well as method for providing nutrition to renal patients. Pursuant to the present invention, the enteral composition includes an effective amount of...
|
|
|
5728683 |
External escinol preparation for skin
An external preparation for skin comprising at least one member selected from the group consisting of escinol and its salts represented by the following constitutional formula (1): ##STR1##...
|
|
|
5728736 |
Reduction of hair growth
Mammalian hair growth is reduced by applying to the skin a dermatologically acceptable composition including an inhibitor of arginase.
|
|
|
5728675 |
Antemortem nutrient supplement for livestock
The invention relates to an antemortem stress supplement for livestock containing one or more sources of electrolytes including sodium, potassium and magnesium, one or more sources of amino acids...
|
|
|
5723448 |
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction
Administration of argininosuccinate synthetase activity reducing agents, e.g., argininosuccinate synthetase induction blocking agents (e.g., antibiotics that bind to DNA sequences present in the...
|
|
|
5721278 |
Ovulation control by regulating nitric oxide levels
Inhibition of ovulation in a female may be achieved by administering a nitric oxide synthase inhibitor, alone or in combination with one or more of a progestin, an estrogen, and an LH-RH...
|
|
|
5719119 |
Parenteral nutrition therapy with amino acids
Parenteral nutrition aqueous solutions are provided which preferably contain glutamine together with other organic nitrogen containing compounds. The respective concentrations of the compounds...
|
|
|
5719133 |
Adolescent dietary composition
A dietary composition comprising, based on total caloric content of the composition, a) a carbohydrate component which comprises from 50 to 65% of the total caloric content; b) a lipid...
|
|
|
5719134 |
Method of providing nutrition to adolescents
A dietary composition comprising, based on total caloric content of the composition, a) a carbohydrate component which comprises from 50 to 65% of the total caloric content; b) a lipid...
|
|
|
5716976 |
Method of treatment for carbohydrate addiction
A method is described for alleviating carbohydrate addiction by administration of anorexients on a schedule that avoids tolerance to the anorexient.
|
|
|
5690967 |
Compositions for improved topical delivery of lactic acid
Compositions for improved topical delivery of lactic acid comprising lactic acid and an amphoteric or pseudoamphoteric agent.
|
|
|
5686493 |
Method for protecting against endotoxin-induced shock using ornithine
A method for the prophylaxis of shock in a patient induced by endotoxin or bacteremia is disclosed. The method involves administering a therapeutically effective amount of a chemical composition...
|
|
|
5686491 |
Infant formula
The present invention provides an infant formula for infants with metabolic disorders in fatty acid catabolism such as medium-chain acyl-CoA dehydrogenase deficiency (MCAD), long-chain acyl-CoA...
|
|
|
5672590 |
Pharmaceutical composition for immunomodulating and adjuvant treatment
Pharmaceutical composition for immunomodulating and adjuvant therapy containing a metabolic stressor, 2-deoxy-D-ribose and further active components, i.e. ribose, DL-alanine, nicotonic acid,...
|
|
|
5670539 |
Treatment of movement disorders using large neutral amino acids
The present invention relates to a method of remitting or attenuating the symptoms of movement disorders which can be secondary to treatment of psychiatric disorders with antipsychotic drugs mainly...
|
|
|
5665371 |
Medicines which contain derivatives of proline or hydroxyproline
Pharmaceutical compositions which comprise, as an active substance, (N-alkyl) derivatives of proline or hydroxyproline. Such compositions are useful in the treatment of cancer.
|
|
|
5663208 |
Antifungal wound healing compositions and methods for preparing and using same
This invention pertains to therapeutic antifungal-wound healing compositions. The compositions comprise a therapeutically effective amount of an antifungal agent and a wound healing compositions....
|
|
|
5663203 |
Agents containing prostacyclin derivatives for topical application
The invention relates to a dermal application form of prostacyclin derivatives of Formula I ##STR1## wherein R 1 means hydrogen or alkyl of 1-10 carbon atoms, A is a --CH 2 --CH 2 --,...
|
|
|
5658957 |
Immunostimulating wound healing compositions and method for preparing and using same
This invention pertains to therapeutic immunostimulating-wound healing compositions. The compositions comprise a therapeutically effective amount of an immunostimulating agent and a wound healing...
|
|
|
5656668 |
Hydroxy alkyl amides of dicarboxylic acids and their use in cosmetic compositions
A class of pseudoceramide having the formula shown in which: R1 is a hydrocarbon group; R2-R8 are each independently H or CH 3 ; R9 and R10 are each independently H or hydrocarbon group of up to...
|
|
|
5654278 |
Composition and method comprising growth hormone and leucine
A pharmaceutical formulation comprising a growth hormone and leucine shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows...
|
|
|
5650172 |
Pharmaceutical preparation comprising fat emulsion of fat microparticles
A preparation comprising a fat emulsion of fat microparticles wherein said emulsion contains a stabilizer consisting essentially of a fatty acid, a basic amino acid and a saccharide is provided. In...
|
|
|
5650149 |
Cosmetic composition for proliferating indigenous bacteria on skin
A cosmetic composition containing triglyceride oleate and yeast extract and further, if desired, an L-cysteine hydrochloride as components for proliferating indigenous bacteria on the skin.
|